Logo for LaunchBio Program: WebinarsLogo for LaunchBio Program: Webinars

Connecting Biotech Entrepreneurs with Knowledge, Capital, and Talent



Understanding Tax Credits and Incentives for Biotech Startups


Where do you start? Taxes often feel like a minefield with ever-changing rules and regulations, but it doesn’t have to always be that way. For example, did you know that life science and biotech startups and their investors have several options for potential tax credits and incentives? Federal and state governments see the value of these companies, and tax incentives have been designed to encourage, support, and give opportunity to early stage companies and the investors who fund them.

In this webinar, entrepreneurs and investors will gain an understanding of the pros & cons of entity types, the ever-changing landscape concerning deductibility, tax implications of equity compensation (and balancing compliance with talent acquisition), tax credits and incentives, and how to take advantage of various credits and exemptions (R&D tax credits, R&D payroll credits, orphan drug credits, sales tax exemptions, angel investor credits, and the change in tax treatment for R&D).

Hundreds of companies and investors each year are taking advantage of these options, and with the help of our expert panel, you too may more clearly see your options and how to take full advantage of available opportunities.


  • Tom Fagley, Partner, Hughes Pittman & Gupton, LLP

    Tom Fagley, Partner, Hughes Pittman & Gupton, LLP

    Tom is currently the leader of the Firm’s life science practice and has 25 years of experience, 19 in public accounting and six in private practice. Tom was previously a controller and CFO with a sports travel company. Tom joined Hughes Pittman & Gupton, LLP (“HPG”) in November 2006, and became a partner in January 2014. Tom works with both public and nonpublic companies. Tom’s primary focus is life science clients. Tom has experience with biotechnology, pharmaceutical, medical device, contract research organizations, software, professional services, distribution, and venture capital funds. Tom is a licensed CPA in North Carolina and Texas.

  • Adam Buchanan, Partner, Hughes Pittman & Gupton, LLP

    Adam Buchanan, Partner, Hughes Pittman & Gupton, LLP

    Adam is part of HPG’s corporate tax practice. He has experience working with clients in a variety of industries including biomedical and pharmaceutical, software and technology development, manufacturing and distribution, retail and hospitality, and venture funds. His experience also includes working with owner-managed businesses in a variety of industries, from the start-up phase to eventual exit by the owner. Adam has focused a significant portion of his career on accounting for income taxes pursuant to ASC 740, including Accounting for Uncertain Tax Positions, SEC reporting, and internal controls of the tax function for SOX compliant companies.

  • Tom Geraghty, Partner, DLA Piper

    Tom Geraghty, Partner, DLA Piper

    Tom advises clients on structuring and tax aspects of complex domestic and cross-border business transactions, including mergers and acquisitions (including SPAC and up-C structures), joint ventures, public and private offerings of securities, debt and equity restructurings, real estate transactions, the organization and operation of investment funds, and investments in cryptocurrency and digital assets.

no tags added to this event